健康元：健康元药业集团股份有限公司2021年第三季度报告（英文版）.PDF

1、Joincare Pharmaceutical Group Industry Co.,Ltd.2021 Third Quarterly Report 1/18 Stock code：600380 Stock abbreviation：健康元 Joincare Pharmaceutical Group Industry Co.,Ltd.2021 Third Quarterly Report Board of Directors(the“Board”)and all directors of the Company hereby warrant that there are no false re

2、presentations,misleading statements or material omissions contained in the third quarterly report(the“Report”),and severally and jointly accept responsibility for the truthfulness,accuracy and completeness of the contents of the Report.IMPORTANT NOTICE:The Board,the Supervisory Committee and the dir

3、ectors,supervisors and senior management of the Company hereby warrant the truthfulness,accuracy and completeness of the contents of the Report,and that there are no false representations,misleading statements or material omissions contained in the Report,and severally and jointly accept responsibil

4、ity.The person-in-charge of the Company,the person-in-charge of the Companys accounting work and the person-in-charge of the accounting department(the head of the accounting department)hereby warrant the truthfulness,accuracy and completeness of the financial statements contained in the Report.Wheth

5、er the third quarterly financial statements are audited Applicable N/A The Report is prepared in both Chinese and English.In case of any ambiguity in the understanding of the Chinese and English texts,the Chinese version shall prevail.Joincare Pharmaceutical Group Industry Co.,Ltd.2021 Third Quarter

6、ly Report 2/18 I Principal Financial Data(I)Principal accounting data and financial indicators Unit:Yuan Currency:RMB Item The Reporting Period(July-September 2021)Year-on-Year Change(%)From the beginning of the year to the end of the Reporting Period(January September 2021)Year-on-Year Change(%)Rev